Charles R. Ashby

Drug resistance in cancer: Emerging mechanisms, translational barriers, and pharmacological strategies.

Multidrug resistance (MDR) remains a major challenge in cancer treatment. MDR has been explained by single-gene mechanisms, such as overexpression of ATP-binding cassette (ABC) transporters, drug-target mutations, activation of bypass signaling pathways, and increased DNA repair. However, these mechanisms alone are ins...